🟢 Syncom Formulations is trading 6.82% up today after strong Q1 FY27 results

Syncom Formulations is trading 6.82% up now at INR 17.24 as investors continue responding to strong Q1 FY27 results announced on August 11, 2026.

• Consolidated net profit rose 57.78% to Rs 24.85 crore; sales increased 7.38% to Rs 125.53 crore.
• Operating margin expanded to 20.88% from 13.52%.
• The board recommended a Rs 0.10-per-share final dividend. No separate August 24 announcement or explicit same-day attribution was found.